Search

Displaying results 9971 - 9980 of 10000 in total
  1. Drug

    BN‐Brachyury vaccine

    go.drugbank.com/drugs/DB17425
    Experimental

    BN‐Brachyury vaccine is a novel prime‐boost therapeutic cancer immunotherapy. It is composed of the [MVA-BN-brachyury-TRICOM vaccine] and the fowlpox virus(FPV)‐Brachyury booster vaccine.[A255173]

  2. Drug

    BSK02

    go.drugbank.com/drugs/DB17434
    Experimental

    BSK02 is a Sperm Protein-17 oral microparticle vaccine

  3. Drug

    D-3082-L

    go.drugbank.com/drugs/DB17440
    Experimental

    D-3082-L is one of the components of the human papilloma virus (HPV) type 16 E6/E7 synthetic long peptide (SLP) vaccine ISA101b.

    Synonyms: ISA101 component D-3082-L, ISA101B component D-3082-L
  4. Drug

    BB-1701

    go.drugbank.com/drugs/DB17443
    Investigational

    BB-1701 is a humanized IgG1 kappa monoclonal antibody (anti-HER2 antibody) conjugated to eribulin developed by Bliss Biopharmaceutical.

  5. Drug

    F6-734

    go.drugbank.com/drugs/DB17444
    Experimental

    F6-734 is a bispecific monoclonal antibody with affinity for anticarcinoembryonic antigen (CEA) and anti-diethylenetriamine pentaacetic acid (DTPA) (hMN-14 × m734).[A255217,A255222]

  6. Drug

    Inetetamab

    go.drugbank.com/drugs/DB17457
    Investigational

    Inetetamab is a trastuzumab analog. It differs from trastuzumab by a two amino acid variation in its Fc domain (allotype variation), and possesses an exact F(ab’)2 of trastuzumab.

  7. Drug

    TASO-001

    go.drugbank.com/drugs/DB17463
    Investigational

    TASO-001 is a transforming growth factor (TGF)-beta 2 specific antisense oligodeoxynucleotide.

  8. Drug

    KF-0210

    go.drugbank.com/drugs/DB17476
    Investigational

    KF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.

  9. Drug

    BI-836880

    go.drugbank.com/drugs/DB17484
    Investigational

    BI-836880 is a humanized bispecific nanobody that targets VEGF and Ang2.

  10. Drug

    CPGJ602

    go.drugbank.com/drugs/DB17485
    Investigational

    CPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody.